All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
ELVN / Enliven Therapeutics, Inc.
|
|
|
|
|
|
|
|
BBW / Build-A-Bear Workshop, Inc. Put
|
|
|
|
|
|
|
|
BBW / Build-A-Bear Workshop, Inc.
|
|
|
|
|
|
|
|
TIL / Instil Bio, Inc.
|
|
|
|
|
|
|
|
VRCA / Verrica Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
ADVM / Adverum Biotechnologies, Inc.
|
|
|
|
|
|
|
|
WING / Wingstop Inc. Put
|
|
|
|
|
|
|
|
NXTC / NextCure, Inc.
|
|
|
|
|
|
|
|
CALC / CalciMedica, Inc.
|
|
|
|
|
|
|
|
ORMP / Oramed Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
LENZ / LENZ Therapeutics, Inc.
|
|
|
|
|
|
|
|
BIL / SPDR Series Trust - SPDR Bloomberg 1-3 Month T-Bill ETF
|
|
|
|
|
|
|
|
ASTC / Astrotech Corporation
|
|
|
|
|
|
|
|
ABIO / ARCA biopharma, Inc.
|
|
|
|
|
|
|
|
ACRS / Aclaris Therapeutics, Inc.
|
|
|
|
|
|
|
|
GRPH / Graphite Bio, Inc.
|
|
|
|
|
|
|
|
QQQ / Invesco QQQ Trust, Series 1 Put
|
|
|
|
|
|
|
|
RAIN / Rain Enhancement Technologies Holdco, Inc.
|
|
|
|
|
|
|
|
/ THESEUS PHARMACEUTICALS INC
|
|
|
|
|
|
|
|
FIXX / Homology Medicines, Inc.
|
|
|
|
|
|
|
|
/ Tourmaline Bio, Inc.
|
|
|
|
|
|
|
|
NGNE / Neurogene Inc.
|
|
|
|
|
|
|
|
CYTT / Cyteir Therapeutics, Inc.
|
|
|
|
|
|
|
|
KNTE / Kinnate Biopharma Inc.
|
|
|
|
|
|
|
|
RPHM / Reneo Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ATHA / Athira Pharma, Inc.
|
|
|
|
|
|
|
|
MIST / Milestone Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
QTTB / Q32 Bio Inc.
|
|
|
|
|
|
|
|
ALVR / AlloVir, Inc.
|
|
|
|
|
|
|
|
LSTA / Lisata Therapeutics, Inc.
|
|
|
|
|
|
|
|
ELYM / Eliem Therapeutics, Inc.
|
|
|
|
|
|
|
|
CNTB / Connect Biopharma Holdings Limited - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
TLIS / Talis Biomedical Corporation
|
|
|
|
|
|
|
|
DSGN / Design Therapeutics, Inc.
|
|
|
|
|
|
|
|
FBRX / Forte Biosciences, Inc.
|
|
|
|
|
|
|
|
SGOV / iShares Trust - iShares 0-3 Month Treasury Bond ETF
|
|
|
|
|
|
|
|
PMVP / PMV Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ADVM / Adverum Biotechnologies, Inc.
|
|
|
|
|
|
|
|
AVRO / AVROBIO, Inc.
|
|
|
|
|
|
|
|
AVIR / Atea Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
VTGN / Vistagen Therapeutics, Inc.
|
|
|
|
|
|
|
|
ANF / Abercrombie & Fitch Co.
|
|
|
|
|
|
|
|
ANF / Abercrombie & Fitch Co. Put
|
|
|
|
|
|
|
|